"Interventions to Slow Aging in Humans: Are We Ready?"
“减缓人类衰老的干预措施:我们准备好了吗?”
基本信息
- 批准号:8597898
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgeAgingBiomedical ResearchBirthCardiovascular DiseasesChronicChronic DiseaseClinicalClinical Drug DevelopmentClinical TrialsConsensusConsensus WorkshopDeveloped CountriesDeveloping CountriesDevelopmentDiabetes MellitusDietDiseaseDrug TargetingEducational workshopExperimental Animal ModelFundingGene MutationGerontologyGoalsGovernmentGrowthGuidelinesHealthHealth BenefitHealthcareHumanHypertensionIncidenceIndustryInterventionItalyLearningLife ExpectancyLongevityMacaca mulattaMalignant NeoplasmsMeasuresMutationNerve DegenerationNutrientPathologyPathway interactionsPharmaceutical PreparationsPharmacologic SubstancePopulationPrevalenceRegimenRequest for ApplicationsResearchRisk FactorsRodentSafetySicilySignal PathwaySocial WelfareStructureSystemTaxesTechniquesTestingUnited StatesWorkage relateddetection of nutrientdietary restrictiondrug developmentdrug discoverydrug testinggenetic manipulationimprovedloss of functionpre-clinicalpublic health relevancesuccesssymposiumtrendtumor
项目摘要
DESCRIPTION (provided by applicant): Human aging and age-associated diseases are becoming one of the biggest challenges faced by developed and developing countries. The financial burden caused by these chronic diseases is already overwhelming and currently taxing the healthcare and welfare systems of developed nations, but if present trends continue, the challenges could overwhelm the systems. In rodents, both dietary restriction (DR) and mutations in nutrient and growth signaling pathways can extend longevity by 30-50% but also lower the incidence of age-related loss of function and disease, including tumors and neurodegeneration. This application requests funds to support the Consensus Workshop "Interventions to Slow Aging in Humans: Are We Ready?" to be held in Erice, Sicily, Italy, from October 8-13, 2013. The main aim of the consensus workshop is to bring together leading experts in gerontology, drug discovery and development to begin to obtain consensus related to the discovery and development of safe interventions to slow aging and increase healthspan in humans. The goals of the conference are: 1) To determine the most suitable candidate healthspan interventions/drugs for clinical development, 2) To provide a forum for the discussion of state of the art techniques for drug discovery related to aging and age-related disease, 3) To stimulate clinical trials to begin the testing of drugs generated by basic biogerontology research and discuss the potential pitfalls and side effects of each drug.
描述(由申请人提供):人类衰老和与年龄相关的疾病正在成为发达国家和发展中国家面临的最大挑战之一。这些慢性病造成的经济负担已经不堪重负,目前正在给发达国家的医疗保健和福利系统带来负担,但如果目前的趋势继续下去,这些挑战可能会压垮这些系统。在啮齿动物中,饮食限制 (DR) 以及营养和生长信号通路的突变可以将寿命延长 30-50%,同时还可以降低与年龄相关的功能丧失和疾病(包括肿瘤和神经退行性疾病)的发生率。本申请请求资金支持共识研讨会“人类延缓衰老的干预措施:我们准备好了吗?”将于 2013 年 10 月 8 日至 13 日在意大利西西里岛埃里切举行。共识研讨会的主要目的是汇集老年学、药物发现和开发领域的领先专家,开始就老年学、药物发现和开发方面的领先专家达成共识。减缓人类衰老和延长健康寿命的安全干预措施。会议的目标是:1) 确定最适合临床开发的候选健康寿命干预措施/药物,2) 提供一个论坛,讨论与衰老和年龄相关疾病相关的药物发现的最先进技术, 3) 刺激临床试验,开始测试基础生物老年学研究产生的药物,并讨论每种药物的潜在陷阱和副作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VALTER D. LONGO其他文献
VALTER D. LONGO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VALTER D. LONGO', 18)}}的其他基金
Periodic Fasting, GHR/IGF-1, Multisystem Regeneration, and Healthspan
定期禁食、GHR/IGF-1、多系统再生和健康寿命
- 批准号:
10374749 - 财政年份:2018
- 资助金额:
$ 1.5万 - 项目类别:
Periodic Fasting, GHR/IGF-1, Multisystem Regeneration, and Healthspan
定期禁食、GHR/IGF-1、多系统再生和健康寿命
- 批准号:
10816720 - 财政年份:2018
- 资助金额:
$ 1.5万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8018805 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Dietary Restriction, GH/IGF-l & Mechanisms of Cellular Protection and Regeneration
饮食限制,GH/IGF-l
- 批准号:
9074571 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8240033 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8816020 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8429461 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8643557 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
相似国自然基金
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
年龄结构和空间分布对艾滋病的影响:建模、分析与控制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
早期抗肌生长抑制素治疗成骨不全症的临床前测试
- 批准号:
10840238 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别: